Get to know us
EPTRI is a Research Infrastructure aiming to promote paediatric research and provide optimal support to facilitate the accruing of knowledge in the many research fields necessary to guarantee the access to high quality and safe paediatric medicine
![002-witness](https://eptri.eu/wp-content/uploads/2021/04/002-witness.png)
VISION
To increase knowledge on children growth and ontogeny characteristics relevant for the identification of novel therapies dedicated to children and to provide services for their development
![001-startup](https://eptri.eu/wp-content/uploads/2021/04/001-startup.png)
MISSION
To implement competences, research strategies, access to key technologies, standardised models, and analytical tools and to offer to public and private stakeholders qualified basic, preclinical and translational research services covering paediatric medicines discovery and development
Latest News
HMA – EMA 3rd EU Big Data Stakeholder Forum
The Heads of Medicines Agencies - European Medicines Agency (HMA - EMA) Big Data Steering Group is organizing the 3rd EU Big Data Stakeholders Forum...
EMA’s raw data proof-of-concept pilot for industry
The European Medicines Agency (EMA) has launched a pilot project to i) assess whether the analysis of ‘raw data’ from clinical trials by regulatory...
General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry
The U.S. Food and Drug Administration (FDA) has recently published a guidance on neonatal clinical pharmacology studies. This guidance is intended...